Cutaneous leishmaniasis
Researchers from Hazara University in Pakistan have conducted a retrospective study on cutaneous leishmaniasis (CL) in the north-west region of the country. The study, published in BMC Public Health in 2025, reveals a high prevalence of CL in the region, particularly among patients under 20 years of age and in
Cutaneous leishmaniasis
Researchers from Hazara University in Pakistan have conducted a retrospective study on cutaneous leishmaniasis (CL) in the north-west region of the country. The study, published in BMC Public Health in 2025, reveals a high prevalence of CL in the region, particularly among patients under 20 years of age and in
Cutaneous leishmaniasis
A recent study has highlighted the risk of an allergic response to meglumine antimoniate, a treatment for cutaneous leishmaniasis, which in rare cases can lead to severe and potentially life-threatening reactions. The study, conducted by researchers at University College London (UCL) Hospitals NHS Foundation Trust, describes a case of a
